This information was provided by strainprint.ca Send your Press Release here. Strainprint™ Technologies, Lumir Lab and Gynica Announce Clinical Trial Partnership Establishing World’s First and Largest Database of Medical Cannabis Effects on Women International Study Monitoring Real-time Cannabis Treatment for the Symptoms of Endometriosis Will Leverage … [Read more...] about Strainprint™ Technologies, Lumir Lab and Gynica Announce Clinical Trial Partnership Establishing World’s First and Largest Database of Medical Cannabis Effects on Women
Archives for November 2018
Cannabis Companies Double Barrel And Verano™ Announce Exclusive Partnership And Expansion
This information was provided by prnewswire Send your Press Release here. Partnership Cements Double Barrel's Availability In Four States, Following Verano's $120 Million Financing Announcement LOS ANGELES, Nov. 15, 2018 /PRNewswire/ -- Double Barrel, the world's first, patented dual-oil chamber vaporizer created for the sophisticated, yet overlooked … [Read more...] about Cannabis Companies Double Barrel And Verano™ Announce Exclusive Partnership And Expansion
All Women’s Cannabis Social Group Re-Brands to Glowing Goddess Getaway
This information was provided by bellivy.com Send your Press Release here. Los Angeles, CA -- Nov. 15, 2018 -- Having established themselves as a pioneer in the cannabis movement since 2016, the Ganja Goddess Getaway, the first female-founded and female lead all women's cannabis retreat is undergoing a re-brand and will now be known as the Glowing Goddess Getaway … [Read more...] about All Women’s Cannabis Social Group Re-Brands to Glowing Goddess Getaway
InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
This information was provided by prnewswire Send your Press Release here. VANCOUVER, Nov. 12, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high … [Read more...] about InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
Beleave Introduces 90 New Cannabis Varieties as it Secures Genetics Acquisition Agreements
This information was provided by prnewswire Send your Press Release here. TORONTO, Nov. 12, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has secured genetics acquisition agreements for a broad range of cannabis seed varieties from diverse lineages. There will be a total of 90 new varieties introduced … [Read more...] about Beleave Introduces 90 New Cannabis Varieties as it Secures Genetics Acquisition Agreements